Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres.

Background And Aim: Transarterial radioembolization with yttrium-90 microspheres is one treatment option for inoperable hepatocellular carcinoma. We compared the survival in a cohort of patients receiving radioembolization or no radioembolization.

Methods: The data of 46 patients referred for radioembolization was retrospectively reviewed.